Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parkinson's Disease

  Free Subscription


08.11.2021

1 BMC Neurol
1 BMC Neurosci
1 Mov Disord
1 Nat Rev Neurol
2 Nature
1 Nervenarzt
1 Neurobiol Dis
1 Neuropsychology
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Neurol

  1. NEUMANN S, Taylor J, Bamford A, Metcalfe C, et al
    Cholinesterase inhibitor to prevent falls in Parkinson's disease (CHIEF-PD) trial: a phase 3 randomised, double-blind placebo-controlled trial of rivastigmine to prevent falls in Parkinson's disease.
    BMC Neurol. 2021;21:422.
    PubMed         Abstract available


    BMC Neurosci

  2. SEO MH, Lim S, Yeo S
    Association of decreased triadin expression level with apoptosis of dopaminergic cells in Parkinson's disease mouse model.
    BMC Neurosci. 2021;22:65.
    PubMed         Abstract available


    Mov Disord

  3. ARPIN DJ, Mitchell T, Archer DB, Burciu RG, et al
    Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline.
    Mov Disord. 2021 Nov 1. doi: 10.1002/mds.28838.
    PubMed         Abstract available


    Nat Rev Neurol

  4. FYFE I
    APOE epsilon4 influences Parkinson disease progression.
    Nat Rev Neurol. 2021 Nov 3. pii: 10.1038/s41582-021-00585.
    PubMed        


    Nature

  5. GONZALEZ-RODRIGUEZ P, Zampese E, Stout KA, Guzman JN, et al
    Disruption of mitochondrial complex I induces progressive parkinsonism.
    Nature. 2021 Nov 3. pii: 10.1038/s41586-021-04059.
    PubMed         Abstract available

  6. DORIC Z, Nakamura K
    Mice with disrupted mitochondria used to model Parkinson's disease.
    Nature. 2021 Nov 3. pii: 10.1038/d41586-021-02955.
    PubMed        


    Nervenarzt

  7. LEVIN J, Nubling G, Giese A, Janzen A, et al
    [Neuroprotective treatment of idiopathic, genetic and atypical Parkinson's disease with alpha-synuclein-Pathology].
    Nervenarzt. 2021 Nov 4. pii: 10.1007/s00115-021-01220.
    PubMed         Abstract available


    Neurobiol Dis

  8. NORDSTROM E, Eriksson F, Sigvardson J, Johannesson M, et al
    ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson's disease.
    Neurobiol Dis. 2021 Nov 1:105543. doi: 10.1016/j.nbd.2021.105543.
    PubMed         Abstract available


    Neuropsychology

  9. JAEGER A, Tavares MDD, Gomide GFD, Cardoso F, et al
    Episodic memory for emotional and neutral pictures in Parkinson's disease.
    Neuropsychology. 2021 Oct 28. pii: 2021-99195-001. doi: 10.1037/neu0000779.
    PubMed         Abstract available


    PLoS One

  10. PRELL T, Liebermann JD, Mendorf S, Lehmann T, et al
    Pain coping strategies and their association with quality of life in people with Parkinson's disease: A cross-sectional study.
    PLoS One. 2021;16:e0257966.
    PubMed         Abstract available

  11. BAILEY DK, Clark W, Kosman DJ
    The iron chelator, PBT434, modulates transcellular iron trafficking in brain microvascular endothelial cells.
    PLoS One. 2021;16:e0254794.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  12. AHUJA M, Ammal Kaidery N, Attucks OC, McDade E, et al
    Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: